Pathobiology of lymphoid and myeloid blast crisis and management issues.

Ilaria, Robert L

Ilaria, Robert L.

Affiliation

Ilaria RL; University of Texas Southwestern Medical Center, USA. ilariaro@lilly.com

Hematology Am Soc Hematol Educ Program ; : 188-94, 2005.

Article in En | MEDLINE | ID: mdl-16304379

Subject(s)

Antineoplastic Agents/adverse effects; Blast Crisis/chemically induced; Leukemia, Myelogenous, Chronic, BCR-ABL Positive/drug therapy; Piperazines/adverse effects; Protein-Tyrosine Kinases/antagonists & inhibitors; Pyrimidines/adverse effects; Algorithms; Antineoplastic Agents/therapeutic use; Benzamides; Blast Crisis/drug therapy; Blast Crisis/genetics; Blast Crisis/physiopathology; Fusion Proteins, bcr-abl/metabolism; Genes, abl; Genomic Instability; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive/pathology; Mutation; Protein-Tyrosine Kinases/metabolism

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Piperazines / Pyrimidines / Protein-Tyrosine Kinases / Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Blast Crisis / Antineoplastic Agents Limits: Humans Language: En Journal: Hematology Am Soc Hematol Educ Program Journal subject: HEMATOLOGIA Year: 2005 Document type: Article Affiliation country: United States Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links